4 Results for "

nascent polypeptide chains

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "nascent polypeptide chains" in MCE Product Catalog:

Cat. No.: HY-P5723A
Target:  

Bacterial

Research Areas:  

Infection

Api137 TFA is an antimicrobial peptide that interferes with bacterial growth by inhibiting translation. Api137 TFA inhibits protein synthesis by trapping of release factors on the 70S ribosome following hydrolysis of the nascent polypeptide chain .
loading...
    loading...
Cat. No.: HY-P5723
CAS No.: 1428789-03-0
Target:  

Bacterial

Research Areas:  

Infection

Api137 is an antimicrobial peptide that interferes with bacterial growth by inhibiting translation. Api137 inhibits protein synthesis by trapping of release factors on the 70S ribosome following hydrolysis of the nascent polypeptide chain .
loading...
    loading...
Cat. No.: HY-186313
CAS No.: 3079914-21-6
Research Areas:  

Cancer

PTC-IN-1 is a human ribosomal peptidyl transferase center (PTC) inhibitor. PTC-IN-1 forms stable interactions with 28S rRNA and undergoes steric-hindrance electrostatic interactions with nascent polypeptide chains, thereby inducing context-dependent translation arrest. PTC-IN-1 activates the ribotoxic stress response through phosphorylation of p46 and p54 JNK, triggers ribosome collisions, and activates the integrated stress response via phosphorylation of eIF2α. PTC-IN-1 inhibits the proliferation of cancer cells. PTC-IN-1 can be used in the research of triple-negative breast cancer, prostate cancer, colorectal cancer .
loading...
    loading...
Cat. No.: HY-186311
CAS No.: 3079716-11-0
Target:  

c-Myc JNK

Research Areas:  

Cancer

IDB-003 is an orally active inhibitor of the human ribosomal peptidyl transferase center (PTC). IDB-003 exhibits antiproliferative activity against MYC-dependent cancer cells. IDB-003 binds to PTC, maintains ribosomal RNA interactions, blocks translation via context-dependent nascent polypeptide chain interactions, depletes MYC and CCND1, activates JNK phosphorylation through ribosomal collision, and downregulates the MYC target pathway. IDB-003 inhibits the growth of triple-negative breast cancer xenografts in mice. IDB-003 can be used for the research of triple-negative breast cancer .
loading...
    loading...